Using a dominant negative mutant of Ras and PI3K inhibition, it was demonstrated that Ras and PI3K activation participates in ghrelin-caused proliferation of human colon cancer cells through the activation of the AKT/mTOR pathway [65]. Here, PIK3CD is linked to malignant colon neoplasm.